• lngr
• ETF
• Sector Equity
• Healthcare

Global X Longevity Thematic ETF

Expenses: 0.50% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

• shsax
• Mutual Fund
• Sector Equity
• Healthcare

BlackRock Health Sciences Opportunities Portfolio Investor A Shares

Expenses: 1.12% (Better than 0% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

• shisx
• Mutual Fund
• Sector Equity
• Healthcare

BlackRock Health Sciences Opportunities Portfolio Service Shares

Expenses: 1.15% (Better than 0% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

• gnom
• ETF
• Sector Equity
• Healthcare

Global X Genomics & Biotechnology ETF

Expenses: 0.68% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

• ftxh
• ETF
• Sector Equity
• Healthcare

First Trust Nasdaq Pharmaceuticals ETF

Expenses: 0.60% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

• fshcx
• Mutual Fund
• Sector Equity
• Healthcare

Fidelity® Select Health Care Services Portfolio

Expenses: 0.75% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

• cncr
• ETF
• Sector Equity
• Healthcare

Loncar Cancer Immunotherapy ETF

Expenses: 0.79% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

• bbc
• ETF
• Sector Equity
• Healthcare

Virtus LifeSci Biotech Clinical Trials ETF

Expenses: 0.79% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

• fphax
• Mutual Fund
• Sector Equity
• Healthcare

Fidelity® Select Pharmaceuticals Portfolio

Expenses: 0.77% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

• bbp
• ETF
• Sector Equity
• Healthcare

Virtus LifeSci Biotech Products ETF

Expenses: 0.79% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »